Literature DB >> 12774976

Serum IgM concentrations in normal, fit horses and horses with lymphoma or other medical conditions.

G A Perkins1, D V Nydam, M J B F Flaminio, D M Ainsworth.   

Abstract

The purposes of this study were to (1) prospectively establish serum IgM and IgG concentrations in normal, fit, adult horses over time and (2) determine the accuracy of serum IgM concentrations for diagnosing lymphoma. Serial IgM and IgG concentrations were measured with a radial immunodiffusion assay in 25 regularly exercised horses at 6-week intervals. Horses had serum IgM concentrations ranging from 50 to 242 mg/dL over 5 months, with 20% of horses having IgM < or = 60 mg/dL. The normal range for IgM in fit horses should be considered 103 +/- 40 mg/dL and a cut-point for an IgM deficiency, < or = 23 mg/dL. IgG concentrations ranged from 1,372 to 3,032 mg/dL. Retrospectively, medical records of adult horses (n = 103) admitted to the Cornell University Hospital for Animals for which serum IgM was measured were examined. Horses were categorized as "lymphoma negative" (n = 34) or "lymphoma positive" (n = 18). The sensitivity and specificity of a serum IgM concentration (< or = 60 mg/dL) for detecting equine lymphoma was 50 and 35%, respectively. At the new cut-point (< or = 23 mg/dL), the sensitivity was low at 28% and the specificity improved to 88%. The negative predictive values at various population prevalences indicate that a horse with a high serum IgM (> 23 mg/dL) is unlikely to have lymphoma, whereas the positive predictive value (70%) does not allow for reliable determination of lymphoma in a horse with serum IgM < or = 23 mg/dL. Therefore, serum IgM concentrations should not be used as a screening test for equine lymphoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12774976     DOI: 10.1111/j.1939-1676.2003.tb02458.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  3 in total

1.  Blastomycotic osteomyelitis associated with severe lameness in a horse.

Authors:  José L Méndez-Angulo; Megan E Swaab; Erin Malone; Erik J Olson; Mark D Chalkley; Betsy Aird; Christie Ward
Journal:  Can Vet J       Date:  2011-12       Impact factor: 1.008

2.  Common variable immunodeficiency in horses is characterized by B cell depletion in primary and secondary lymphoid tissues.

Authors:  M Julia B F Flaminio; Rebecca L Tallmadge; Cristina O M Salles-Gomes; Mary Beth Matychak
Journal:  J Clin Immunol       Date:  2008-08-02       Impact factor: 8.317

Review 3.  Hematopoietic neoplasias in horses: myeloproliferative and lymphoproliferative disorders.

Authors:  Ana Muñoz; Cristina Riber; Pablo Trigo; Francisco Castejón
Journal:  J Equine Sci       Date:  2010-01-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.